13728 Federal Register / Vol. 60, No. 49 / Tuesday, March 14, 1995 / Notices

is May 5, 1995. Please note that this is

a departure from the traditional

approach of using postmarks instead of

receipt date to determine eligibility of

applications for review.

ADDRESSES: Application receipt:

Department of Health and Human

Services, ACF Division of Discretionary

Grants, 370 L’Enfant Promenade, S.W.,

Washington, D.C. 20447. Attn: ACF–

93588.951–A.

FOR FURTHER INFORMATION ON THE

COMMUNITY SCHOOLS PROGRAM CONTACT:

Department of Health and Human

Services, AC/ACYF, Family and Youth

Services Bureau, P.O. Box 1182,

Washington, D.C. 20013. Telephone

(202) 205–8076. Information is also

available on the ACF Electronic Bulletin

Board. To access, set modem to No

Parity, 8 Data Bits, 1 Stop Bit and dial

1–800–627–8886. Under ‘‘Program

Office Subsystems, Family and Youth

Services Bureau,’’ relevant files are

found under COMMSCH.

FOR FURTHER INFORMATION ON THE FACES

PROGRAM CONTACT: Department of

Education, OESE, Safe and Drug Free

Schools Program, 600 Independence

Avenue, S.W., Washington, D.C. 20202.

Telephone (202) 260–3954.

Catalog of Federal Domestic Assistance

Number 84.285A for the FACES Program and

Number 93.588 for the Community School

Program.)

Dated: March 7, 1995.

Olivia A. Golden,

Commissioner, Administration on Children,

Youth and Families.

[FR Doc. 95–6252 Filed 3–13–95; 8:45 am]

BILLING CODE 4184–01–P

Centers for Disease Control and

Prevention

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): Cooperative

Agreements for National/Regional

Minority Organization Human

Immunodeficiency Virus (HIV)/Sexually

Transmitted Diseases (STD)

Prevention, Immunization, and

Tuberculosis (TB) Projects-Program

Announcement 305b: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Disease, Disability, and Injury

Prevention and Control SEP: Cooperative

Agreements for National/Regional Minority

Organization HIV/STD Prevention,

Immunization, and TB Projects-Program

Announcement 305b.

Time and Date: 8:30 a.m.-4:30 p.m., April

18, 1995.

Place: Corporate Square, Building 11,

Room 2320, Corporate Square Boulevard,

Atlanta, Georgia 30329.

Status: Closed.

Matters to be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcement 305b.

The applications being reviewed include

information of a confidential nature,

including personal information concerning

individuals associated with the applications.

The meeting will be closed to the public

in accordance with provisions set forth in

section 552b(c) (4) and (6), Title 5 U.S.C., and

the Determination of the Associate Director

for Management and Operations, CDC,

pursuant to Public Law 92–463.

Contact Person for More Information: John

R. Lehnherr, Chief, Resource Analysis Office

(E07), National Center for Prevention

Services, CDC, Corporate Square, Corporate

Square Boulevard, Atlanta, Georgia 30329,

telephone 404/639–8023.

Dated: March 7, 1995.

Arthur C. Jackson,

Associate Director for Management and

Operations, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–6236 Filed 3–13–95; 8:45 am]

BILLING CODE 4163–18–M

Food and Drug Administration

Comparing Treatments: Safety,

Effectiveness, and Cost-Effectiveness;

Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that it is holding a meeting to explore

methodological and regulatory issues in

the design and review of studies

intended to show differences or

similarities among active drug and

biological therapies. As the

pharmaceutical marketplace evolves,

there are new pressures on the

developers of drug/biological products

to demonstrate comparative effects. This

meeting will examine the needs for this

type of information, how the

pharmaceutical industry is responding

to new demands for comparative

information, case-study experience

ruling out biases in study design, the

use of observational studies,

methodological concerns in

effectiveness trials, and promotional

considerations. The study will examine

issues concerning evaluation of safety,

effectiveness, and cost-effectiveness.

DATES: The meeting will be held on

Thursday, March 23, 1995, 8 a.m. to

5:30 p.m., and on Friday, March 24,

1995, 8:30 a.m. to 5 p.m.

ADDRESSES: The meeting will be held at

the National Institutes of Health,

Clinical Center, Bldg. 10, Jack Masur

Auditorium, 9000 Rockville Pike,

Bethesda, MD. Copies of the transcript

of the meeting will be available from the

contact person listed below. There is no

registration fee for this meeting.

Interested persons are encouraged to

register early because space is limited.

FOR FURTHER INFORMATION CONTACT:

Regarding information concerning the

meeting and registration forms: Louis A.

Morris, Center for Drug Evaluation and

Research (HFD–240), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–594–6812,

FAX 301–594–6759.

Dated: March 8, 1995.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 95–6199 Filed 3–13–95; 8:45 am]

BILLING CODE 4160–01–F

Health Resources and Services

Administration

Rural Regional Trauma and Emergency

Medical Services System

Demonstration Grant Project in South

Central Florida

AGENCY: Health Resources and Services

Administration, Public Health Service,

Department of Health and Human

Services.

ACTION: Notice of extension of

application due date.

SUMMARY: This notice extends the

application due date for a Rural

Regional Trauma and Emergency

Medical Services (EMS) Demonstration

Grant Project in South Central Florida.

The application due date for the South

Central Florida project is extended to

May 15, 1995. All other aspects of the

February 15, 1995 Federal Register

Notice remain the same.

Dated: March 9, 1995.

Ciro V. Sumaya,

Administrator.

[FR Doc. 95–6198 Filed 3–13–95; 8:45 am]

BILLING CODE 4160–15–M

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:
Federal Register / Vol. 60, No. 49 / Tuesday, March 14, 1995 / Notices 13729

Commitee Name: National Institute of

General Medical Sciences, Special Emphasis

Panel—Minority Biomedical Research

Support and Undergraduate Program

Expertise.

Date: March 28.

Time: 1 p.m.—adjournment.

Place: Holiday Inn, 348 N. Dupont

Highway, Dover, DE 19901.

Contact Person: Dr. Bruce Wetzel,

Scientific Review Administrator, NIGMS, 45

Center Drive, Room 1AS–19K, Bethesda, MD

20892–6200.

Purpose: To review and evaluate grant

applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The

discussions of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

This notice is being published less than

fifteen days prior to the meeting due to the

urgent need to meet timing limitations

imposed by the grant review cycle.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS].

Dated: March 8, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–6186 Filed 3–13–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

Chronic Fatigue Syndrome Interagency

Coordinating Committee; Public

Meeting

Notice is hereby given of the public

meeting of the Chronic Fatigue

Syndrome (CFS) Interagency

Coordinating Committee, Department of

Health and Human Services, on April

12, 1995 at the Hubert H. Humphrey

Building, Room 729G, 200

Independence Avenue, SW,

Washington, DC.

The meeting will be open to the

public from noon to 3 p.m., on April 12,

to discuss the current CFS activities and

future plans of the various member

agencies. It will be chaired by the

Assistant Secretary for Health. During

the meeting there will be an opportunity

for interested persons to present

information and views on issues related

to CFS. Attendance by the public will be

limited only by space available.

If you plan to attend the meeting,

please provide your name, organization,

address, telephone and FAX numbers to

Dr. John La Montagne, Co-Chair,

Chronic Fatigue Syndrome Interagency

Coordinating Committee, Division of

Microbiology and Infectious Diseases,

National Institute of Allergy and

Infectious Diseases, National Institutes

of Health, Solar Building, Room 3A18

MSC 7630, Bethesda, MD 20892–7630.

Telephone: 301–496–1884, FAX: 301–

480–4528. If you also plan to make a

presentation, please notify Dr. La

Montagne. The time available will be

allocated among the individuals who

request an opportunity for a

presentation (limited to five minutes).

Formal written statements (five copies)

may be presented to the Chair on the

day of the meeting for inclusion in the

minutes.

Dated: March 2, 1995.

Anthony S. Fauci,

Director, NIAID, NIH.

[FR Doc. 95–6188 Filed 3–13–95; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda

To review Small Business Innovation

Research Program grant applications.

Name of SEP: Behavioral and

Neurosciences.

Date: April 14, 1995.

Time: 9 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. A. Keith Murray,

Scientific Review Admin., 5333 Westbard

Ave., Room 325, Bethesda, MD 20892, (301)

594–7145.

Purpose/Agenda

To review individual grant applications

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 23, 1995.

Time: 1 p.m.

Place: NIH, Westwood Building, Room

406B, Telephone Conference.

Contact Person: Dr. Gil Meier, Scientific

Review Administrator, 5333 Westbard Ave.,

Room 406B, Bethesda, MD 20892, (301) 594–

7118.

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 27, 1995.

Time: 1 p.m.

Place: NIH, Westwood Building, Room

406B, Telephone Conference.

Contact Person: Dr. Gil Meier, Scientific

Review Administrator, 5333 Westbard Ave.,

Room 406B, Bethesda, MD 20892, (301) 594–

7118.

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 28, 1995.

Time: 1 p.m.

Place: NIH, Westwood Building, Room

406B, Telephone Conference.

Contact Person: Dr. Gil Meier, Scientific

Review Administrator, 5333 Westbard Ave.,

Room 406B, Bethesda, MD 20892, (301) 594–

7118.

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 29, 1995.

Time: 1 p.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Gil Meier, Scientific

Review Administrator, 5333 Westbard Ave.,

Room 406B, Bethesda, MD 20892, (301) 594–

7118.

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 30, 1995.

Time: 1:30 p.m.

Place: NIH, Westwood Building, Room

406B, Telephone Conference.

Contact Person: Dr. Gil Meier, Scientific

Review Administrator, 5333 Westbard Ave.,

Room 406B, Bethesda, MD 20892, (301) 594–

7118.

Name of SEP: Microbiological and

Immunological Sciences.

Date: March 31, 1995.

Time: 1 p.m.

Place: NIH, Westwood Building, Room

406B, Telephone Conference.

Contact Person: Dr. Gil Meier, Scientific

Review Administrator, 5333 Westbard Ave.,

Room 406B, Bethesda, MD 20892, (301) 594–

7118.

Name of SEP: Multidisciplinary Sciences.

Date: April 3, 1995.

Time: 9 a.m.

Place: NIH, Westwood Bulding, Room 437,

Telephone Conference.

Contact Person: Dr. Paul Parakkal,

Scientific Review Admin., 5333 Westbard

Ave., Room 437, Bethesda, MD 20892, (301)

594–7258.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the grant review cycle.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893. National Institutes of Health,

HHS)